Press release content from Business Wire. The AP news staff was not involved in its creation.
Affinivax Appoints Stuart Chaffee, PhD, as Chief Business Officer
April 20, 2021 GMT
Affinivax Chief Business Officer Stuart Chaffee PhD (Photo: Business Wire)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 20, 2021--
Affinivax, Inc. (“Affinivax”), a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS™ (Multiple Antigen Presenting System) platform, today announced that Stuart Chaffee, PhD, has joined the company as Chief Business Officer. Dr. Chaffee brings to Affinivax extensive experience in business operations, finance and corporate development, including previous roles as Chief Business Officer and CFO at Praxis Precision Medicines and as Head of Business Operations and Co-founder of Kymera Therapeutics.